AIIMS Rishikesh reserves 100 beds for mucormycosis patients

Two teams of doctors have been formed at the facility exclusively for the care of mucormycosis patients for whom separate operation theatres have also been reserved, Dean of hospital affairs, U B Mishra said.

Published On 2021-05-25 04:30 GMT   |   Update On 2021-05-25 04:30 GMT
Advertisement

Rishikesh: Amid rising cases of mucormycosis or black fungus in Uttarakhand, the All India Institute of Medical Sciences here reserved 100 beds, including 10 ICU beds, on Monday for patients suffering from the deadly disease.

Two teams of doctors have been formed at the facility exclusively for the care of mucormycosis patients for whom separate operation theatres have also been reserved, Dean of hospital affairs, U B Mishra said.

Advertisement

Also Read: MSN Labs unveils Posaconazole for Black Fungus treatment in India

Seventy mucormycosis patients are currently admitted at AIIMS, Rishikesh. Six such patients had succumbed at the facility by Sunday night.

Separate arrangements have been made for mucormycosis patients as the number of people suffering from the disease has been rising constantly while most of the beds at the hospital were reserved for COVID-19 patients, Mishra said.

Mucormycosis is a condition that afflicts people post Covid. Covid patients who are also diabetic need to be more careful as they are more vulnerable to the disease, Head of the mucormycosis team and ENT surgeon Amit Tyagi said.

Also Read: Mucormycosis management made handy in covid era: New scoring System for Orbital Exenteration

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News